Metformin lowers blood sugar through a newly found brain pathway
Louis shares a ScienceAlert report on Baylor research showing metformin acts on the brain (VMH, Rap1). He adds that Rap1 is a known longevity pathway that protects telomeres.
5 posts
Louis shares a ScienceAlert report on Baylor research showing metformin acts on the brain (VMH, Rap1). He adds that Rap1 is a known longevity pathway that protects telomeres.

Baylor researchers found metformin activates SF1 neurons in the ventromedial hypothalamus by turning off Rap1. Mice lacking Rap1 did not get the glucose benefit, indicating a brain pathway in addition to liver and gut effects.
A Baylor College of Medicine study in Science Advances found metformin acts largely through the protein Rap1 in SF1 neurons of the hypothalamus. Mice lacking Rap1 in the brain did not respond, and a tiny dose given into the brain lowered glucose. This is preclinical mouse research.
A Science Advances study shows metformin's antidiabetic effect operates partly in the brain, beyond the traditional AMPK explanation. Louis links earlier primate research suggesting brain aging slowing.
Quoted summary of a Science Advances paper suggesting metformin's glucose-lowering effect depends partly on Rap1 signaling in the hypothalamus, not only the liver and gut as long assumed.